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without jailed SB after coronary bifurcation stenting.
Methods: We evaluated 664 patients who underwent successful PCI with DES for
coronary bifurcation lesions from Sejong General Institute PCI database registry
between April 2003 and December 2010. The patients who experienced PCI for left
main bifurcation (n¼146) and with 2 stent technique (n¼55) were sequentially
excluded. The primary endpoint was major adverse cardiac events (MACE), deﬁned
as the composite outcomes of cardiac death, non-fatal myocardial infarction (MI) and
target lesion revascularization. Quantitative coronary angiography was performed in
all study population. The jailed SB was deﬁned as  50% residual stenosis after main
vessel (MV) stenting.
Results: Three-hundred ﬁfty ﬁve patients (76.7%) had not jailed SB, and one hundred
eight patients (23.3%) had it. Jailed group had higher rates of triple vessel disease, true
bifurcation lesion, and SB predilation, and lower rate of ﬁnal kissing balloon dilation,
compared to No- jailed group. Also, Jailed group had longer MV and SB lesion
length. During follow-up (median 34 months), MACE occurred in 37 patients (8.0 %);
10 (9.3%) in the jailed group and 27 (7.6 %) in the No-jailed group (P¼0.56 by log-
rank test). In multivariate analysis, jailed SB was not associated with a higher inci-
dence of MACE (hazard ratio [HR]: 0.69, 95% conﬁdence interval [CI]: (0.32-1.48).
If jailed SB was deﬁned as  75% residual stenosis, jailed SB was still not associated
with a higher incidence of MACE (hazard ratio [HR]: 0.97, 95% conﬁdence interval
[CI]: (0.28-3.35)
Conclusions: Our registry data suggest only angiographic severity of residual stenosis
in SB after MV stenting cannot predict long-term clinical outcome in patients with
coronary bifurcation lesion.TCT-395
Our experience with Absorb -Bioresorbable vascular scaffold in bifurcation
lesions - strategies, immediate results and 30 day outcome
Sengottuvelu G1, Prakashchand Jain2, Sreyes Ravi2
1Apollo Hospitals, Chennai, Tamilnadu, 2Apollo Hospitals, Chennai, Tamil Nadu
Background: Studies have reported the safety and efﬁcacy of Absorb - BVS in Type
A lesions. We present our initial experience of using Absorb in bifurcation lesions.
Methods: From December 2012 to June 2013, we have treated from 9 patients with
12 bifurcation lesions using ABSORB BVS using different strategies. Of these LAD/
diagonal were seen in 8 patients, LCx /OM 3 patients and RCA in 1 patient. The type
of bifurcation were Medina 1, 1, 1 - 4 (33.33); 1, 0, 0 – 4 (33.33 %); 1, 1, 0 – 2 (16.66
%); 0, 0, 1 – 1 (8.33%) and 0,1,1 (8.33 %).
Results:We classiﬁed bifurcation treatment as, B0 (Single wire in main branch, no wire
in side branch), B1 (2 wires in main and side branch and no balloon dilatation of side
branch), B2 (2 wires in main and side branch with balloon dilatation of the side branch
and B3 (2 wires in main and side branch and another scaffold in the side branch). In B2
and B3 cases, we adopted either high pressure snuggle or low pressure kissing balloon
dilatation. Our treatment strategy was B0 – 4 (33.33 %), B1- 5 (41.66 %), B2- 2
(16.66%), B3 - 1 (8.33%). OCT guidance was used in 5 patients (55.55%). Two patients
were treated with B2, of that one had a snuggle dilatation and the other low pressure
kissing. One patient treated with B3 had 2 scaffolds both deployed in LAD and diagonal
using TAP technique and ﬁnal high pressure snuggle. Immediate outcome were good in
all the patients with TIMI III ﬂow, no signiﬁcant residual lesions and no MACE during
hospital stay. There were no scaffold thrombosis orMACE at 30 days clinical follow up.
Conclusions: Our initial experience in small group using ABSORB BVS in bifur-
cation lesions with different strategies showed it is safe to jail the side branch even
without intervention to the side branch. Provisional T stenting strategy and in selected
cases TAP technique is feasible with OCT showing optimal deployment with good
immediate and 30 day outcome will be presented. The strategy of ﬁnal low pressure
kissing balloon vs high pressure snuggle needs to be studied further although high
pressure snuggle has shown promising immediate outcome with good apposition seen
by OCT imaging.TCT-396
Use of ABSORB Bioresorbable vascular scaffold for treatment of Coronary
Bifurcation lesions – “Real ABSORB Registry”
Ashok Seth1, Vinayak Ravisekar1, Vishal Rastogi1, Vijay Kumar1, Arif Mustaqueem1
1Fortis Escorts Heart Institute, Okhla Road, New Delhi 110025 (India), New Delhi,
India
Background: Everolimus eluting ABSORB bioresorbable vascular scaffold (BVS)
represents a novel approach for PCI with transient vessel support and drug delivery
without the long term limitations of metallic DES. It has been approved for unre-
stricted clinical use in many countries including India since late 2012. However
concern exists regarding its use in Bifurcation lesions (BL) and it has been recom-
mended to avoid using across side branch (SB)  2.00 mm. As nearly 20% of the
percutaneous coronary intervention (PCI) are performed for BL, we present on the ﬁrst
experience of the use of ABSORB BVS in BL from our real world “Real ABSORB
Registry”.
Methods: Our “Real ABSORB Registry” is a single centre registry of all BVS
implanted in real life patients since its approval for unrestricted clinical use from
December 2012 onwards.B124 JACC Vol 62/18/Suppl B j October 27 November 1, 2Results: Out of the 108 patients with 136 lesions, 184 BVS was implanted. Among
them 48 patients had Bifurcation lesions treated with 64 BVS. 58% had Medina 1,1,1 ,
33% had 1,1,0 and 9% had 1,0,1 lesions.7/48 (14.5%) patients were planned for two
stent strategy (V stenting in 2 & T stenting in 5) and 41/48 (85.5%) patients were
planned for provisional single stent strategy. Side branch protected with wire and
jailed in 32/48 (66%) patients. SB re crossed through BVS cells in 20/32 (62.5%)
patients.In 12/20 (60%) patients low pressure simultaneous inﬂation of MB and SB
(SNUGGLE inﬂation) done. 3/12 (25%) patients had threatened closure of SB
following Snuggle inﬂation and had SB stenting with BVS using TAP technique. BVS
deployment was successful in all patients and optimal deployment conﬁrmed in 10/48
(20.8%) using OCT. No MACE including Target lesion failure (TLF)and Target
lesion revascularization (TLR) occurred to discharge nor to current clinical follow up
(median 143 days, range 17-163)
Conclusions: Our Real life experience of BVS implantation in bifurcation lesions
with a major SB suggests that use of ABSORB BVS is feasible with successful
deployment and favorable short to mid term follow up. SB access, optimization and
salvage is feasible while stenting Main branch with ABSORB BVS.
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Long-Term Clinical Outcomes of ‘Complete, Incomplete and Reasonably
Incomplete’ Revascularization after Percutaneous Intervention of Unprotected
Left Main Coronary Artery Disease with Drug-Eluting Stent
Yao-Jun Zhang1, Christos Bourantas2, Shao Liang Chen3, Hector Garcia-Garcia4,
Javaid Iqbal5, Takashi Muramatsu6, Patrick W. Serruys2, Bo Xu7
1Nanjing Medical University, Rotterdam, Rotterdam, 2Thoraxcenter, Rotterdam,
Netherlands, 3Nanjing First Hospital, Nanjing Medical University, Jiangsu, China,
4Interventional Cardiology, Rotterdam, The Netherlands, 5Erasmus Medical Center,
Rotterdam, Rotterdam, 6Thoraxcenter, Erasmus Medical Center, Rotterdam,
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Beijing, China
Background: PCI for ULMCA has recently been upgraded to class-IIB indication in
ACC/AHA guidelines. ULMCA disease is frequently associated with distal disease.
However, there are no available data to compare the long-term clinical outcomes in
patients undergoing PCI of ULMCA disease and achieving CR or ICR.
Methods: A total of 910 consecutive patients with ULMCA disease undergoing DES
implantation were prospectively enrolled in the study. Angiographic CR was deﬁned
as revascularization in all diseased segments with diameter 1.5mm (CR-1, according
to the Synergy between PCI with Taxus and cardiac surgery [SYNTAX] classiﬁca-
tion) or 2.5mm (CR-2). Reasonable ICR (R-ICR) was deﬁned as patients having
a diameter stenosis 50% post treatment in diseased segments with diameter between
1.5mm and 2.5mm. The primary endpoint was the incidence of major cardiac adverse
event (MACE: a composite of cardiac death, myocardial infarction [MI] and target
vessel revascularization) at 5-year follow-up.
Results: Angiographic CR-1 was achieved in 386 (42.4%) patients and CR-2 in 613
(67.4%) patients. Patients with ICR had worse outcomes than those that had CR
(MACE: 26.5% vs. 15.5%, p<0.001; all-cause death: 10.1% vs. 6.2%; p¼0.037 in
CR-1 stratiﬁcation; and MACE: 29.6% vs. 18.1%, p<0.001; all-cause death: 12.5%
vs. 6.5%; p¼0.003 in CR-2 stratiﬁcation). Patients with CR or R-ICR (n¼277, 24.9%)
had no difference in mortality (7.0% vs. 6.2%, p¼0.69), though R-ICR group had
higher incidence of MACE, largely driven by repeat revascularization. On multivariate
analysis, the SYNTAX score and presence of multivessel disease and chronic total
occlusion were independent predictors of ICR. Finally, patients with ICR in distal LM
lesions (n¼32, 3.5%) had substantially poor outcome and most of events occurred
within the ﬁrst year follow-up.
Conclusions: Angiographic ICR has a negative impact on long-term clinical
outcomes in the patients with ULMCA disease treated with DES. R-ICR showed
similar safety compared with the strategy of revascularized all diseased vessels with
diameter 1.5mm and may indeed be optimal revascularization strategy in certain
patient groups.
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The Anatomical- and Clinical-based NERS Score II to Predict Clinical Outcomes
after Stenting Unprotected Left Main Coronary Artery Disease: Results from
a Multicenter, Prospective, Registry Study
Shao Liang Chen1, Yaling Han2
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Background: The anatomical, clinical, and procedure-based NERS score was supe-
rior to the SYNTAX score in predicting MACEs after stenting UPLMCA. The
complexity of the calculation was its major limitation.
Methods: The NERS score II was derived from our previous two studies and
externally compared with the NERS and SYNTAX scores in 1463 patients with
UPLMCA who underwent implantation of a DES in a prospective, multicenter,
registry trial. The primary end point was MACEs at one year after the index013 j TCT Abstracts/POSTER/Bifurcation and Left Main Interventions
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revascularization (TVR).
Results: The NERS score II system consisted of 16 (7 clinical and 9 angiographic)
variables. An NERS score II 19 demonstrated enhanced MACE sensitivity and
speciﬁcity of 84.0% and 76.0% (MACE as the state variable), respectively, which
were similar to the NERS score but signiﬁcantly higher compared to the SYNTAX
score. An NERS II score 19 was the only independent predictor of cumulative
MACEs (hazard ratio: 3.27; 95% CI: 1.86 to 5.23; p0.001) and stent thrombosis
(odds ratio: 22.15; 95% CI: 12.47 to 57.92; p0.001) at follow-up
Conclusions: The NERS score II, similar to the conventional NERS score, is more
predictive of MACEs than the SYNTAX score in UPLMCA patients after implan-
tation of a DES.
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Everolimus-Eluting Stent and Dedicated 2-Stent Strategy in Complex ‘True’
Bifurcation Lesion with Major Side Branch Involvement
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New York, New York, NY, 12Mount Sinai Hospital, New York, NY, 13Cardiovascular
Institute, Mount Sinai Medical Center, New York, USA, New York City, NY
Background: Percutaneous coronary intervention (PCI) of complex true coronary
bifurcation lesions is challenging and whether to stent side branch dedicatedly is still
debatable. To date there is no published study showing the safety and efﬁcacy of the
Everolimus-eluting stent (EES) in true bifurcation lesions with major side branch (SB)
involvement treated with dedicated 2 stents (2S). We sought to compare outcomes of
a dedicated 2S with a provisional 1S strategy in these unique patients.
Methods: We identiﬁed 203 patients with complex true bifurcation lesions
(Medina: 1,1,1; 1,0,1; and 0,1,1) with a minimum SB diameter of >2.3mm (assessed
by quantitative coronary angiography) who underwent bifurcation PCI using EES
from February 2010 to December 2011. The PCI strategies included provisional 1S
(n¼96) and dedicated 2S (n¼107) technique. Survival curves were constructed for
time-to-event variables with Kaplan-Meier methodology and compared by log-rank
test.
Results: The baseline characteristics were well matched between two PCI strategies.
In hospital major adverse cardiac event (MACE) and post procedure MI (CK-
MB>3xNormal) (10.42% provisional stent vs. 7.48% 2-Stent implantation, P¼0.46).
At 1-year follow-up, MACE rates were similar for both (2S vs. 1S) techniques. Time
to MACE event analysis is depicted with log rank test (P¼0.31).
Conclusions: With EES use, a dedicated 2S technique appears to be a safe and
effective PCI strategy in patients with complex true bifurcation lesion with large side
branch vessel involvement.JACC Vol 62/18/Suppl B j October 27 November 1, 2013 j TCT AbstrTCT-401
Long Term Follow Up of Patients Undergoing Distal Left Main-Bifurcation
Stenting via Transradial versus Femoral Approach
Wei Liu1, Yujie Zhou1, Yu Yang Liu1, Dong Mei Shi1, Ying Xin Zhao1
1Anzhen Hospital afﬁliated with Capital Medical University, Beijing, China, Beijing,
Beijing
Background: The present study aimed to compare the immediate success and long-
term follow up between the femoral (TF)and transradial (TR) approach for stenting of
unprotected distal left main (LM) bifurcation lesions.
Methods: 412 consecutive patients with distal LM bifurcation lesions underwent stent
implantation (226 in the transradial group and 186 in femoral group) were enrolled.
The primary endpoint was major adverse cardiac events (MACE), a composite of
cardiac death, myocardial infarction, and target vessel revascularization. In hospital
mortality and bleeding, follow up MACE were compared according to vascular access
method.
Results: Clinical and angiographic characteristics (Syntax score) were similar
between groups. 6Fr catheter were more commonly used in TR(100%, TF 15%). 2
stents technique were less commonly used in TR (32% vs 51% P < 0.01). All patients
were implanted with drug eluting stents. For TR patients, bifurcation stent technique
included Culotte (40%), modiﬁed crush (35%), T stent (25%), For TF patients
,bifurcation strategies were crush (60%), T stenting (17%), Culotte (17%) and
kissing or V stenting (6%). Use of intravascular ultrasound were also similar
between two access(40 % versus 36% p¼ 0.42) . No cross over between 2 groups.
No signiﬁcant differences were observed between TR and TF methods for procedural
success (92% TR vs. 96% TR, p ¼ 0.24) or total procedural time. However, duration
of hospital stay and in-hospital occurrence of major or minor bleeding (1.6% vs.
3.5%, p <0.01) were signiﬁcantly lower with TR access. In hospital mortality rate is
similar (TR 0.8% vs. TF 2.1% p¼0.28). Over a median follow-up period of 36
months, rates of MACE did not statistically differ among TR and TF groups (10.6%,
vs. 11.8% p¼ 0.69), respectively. Cox regression showed that two stent (OR 1.21
95%CI 1.05 – 5.12 p < 0.01) but not access route were negative predicative factor
for MACE.
Conclusions: TR access for LM bifurcation stenting is not inferior to TF in term of
efﬁcacy and long term follow-up but associated with decreased rate of bleeding.
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The Efﬁcacy of a “Reversed Wire Technique” for Treating Bifurcation Lesions
in Percutaneous Coronary Intervention -“Tips & Tricks” for salvaging the side
branch -
Masashi Kimura1, Yasushi Asakura1, Yoshihisa Kinoshita1, Tetsuo Matsubara2,
Kenya Nasu2, Takahiko Suzuki1, Tomohiko Teramoto1, Etsuo Tsuchikane1
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Background: An acute side branch occlusion after stent implantation due to unsuc-
cessful wire-crossing of the side branch could induce myocardial damage and
contribute to poor long term outcomes. However, the necessary wiring to cross
extremely angulated bifurcation is distressed.
Methods: The aim of this study was to evaluate the safety and feasibility of
a “Reversed Wire Technique [RWT]” for treating bifurcation lesions in PCI. This
technique requires hydrophilic-coated wire with a hairpin bend curve at the tip and
a double lumen microcatheter.
Results: Of 3,847 consecutive lesions treated with PCI from Aug 2009 to May 2013,
RWT was used in 21 cases including 7 CTO cases. Of 18 bifurcation lesions treated
with RWT, 18 cases had previous failed attempts of wiring to the side branch via
regular methods (The mean number of used wire before RWT was 1.70.9). The
bifurcation lesions treated with RWT were most frequently located in the left anterior
descending artery (57%) followed by the left circumﬂex artery (24%), and the right
coronary artery (19%). The mean angle between the main-vessel and the side-branch
was 13121 degrees. Successful wire crossing was achieved in 81% of cases. All
cases using RWT underwent kissing-balloon inﬂation after wire-crossing. The
patency of the side-branch immediately after the procedure was 100%, if RWT was
successful.
Conclusions: The RWT is a useful method for the salvage of extremely angulated
bifurcation lesions and for eliminating wasted wire, although this technique required
several “Tips and Tricks”. This technique also can be applied to CTO procedure.acts/POSTER/Bifurcation and Left Main Interventions B125
